Skip to content
Screener

Merit Medical Systems MMSI Foundational — Revenue

Other product segments

Therapeutic
$126.4M—

Similar metrics at other companies

HRO
HROWOther Revenues — Revenue
$73K-15.1%
Oracle logo
ORCLCloud Revenues — Revenue
$9.91B+47.1%
Oracle logo
ORCLSoftware Revenues — Revenue
$6.82B-2.1%
Blue Owl Capital logo
OWLPerformance revenues — Revenue
$6.07M-3.9%
EAT
EATFranchise revenues — Revenue
$14.7M+21.5%
Cinemark Holdings logo
CNKOther Revenues — Revenue
$113.1M+18.2%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$5.24B+5.8%
Enterprise value$5.57B+2.6%
P/E37.6×-4.0×
P/S3.4×-0.1×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Merit Medical Systems’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:23 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000856982-26-000025
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
Foundational$255,479$240,382
Therapeutic126,398114,969
Total$381,877$355,351

Item 1. Financial Statements (Unaudited)

FAQ

What is Merit Medical Systems's foundational — revenue?
Merit Medical Systems (MMSI) reported foundational — revenue of $255.48M in Q1 2026.
What does foundational — revenue mean?
This metric represents the total net revenue generated from the sale of products or services within the foundational business segment, excluding any sales-based taxes collected from customers. It serves as a primary indicator of the core commercial performance and market demand for the company's established medical device portfolio. By isolating this segment, investors can evaluate the stability and growth trajectory of the firm's baseline revenue streams independent of newer or non-core business activities.

Ask your AI about Merit Medical Systems's foundational — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude